CTI BIOPHARMA CORP: capex

Value{"amount": 0, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2021-01-01 – 2021-12-31
Statuscurrent
EntityCTI BIOPHARMA CORP
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000891293-22-000010 · Open the official SEC filing →
Retrieved: 2026-08-19T08:57:46.154821+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000891293/capex/2021-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/19eabd2c-6510-4e6a-a8d3-0dff18324384

History

From the Record